Recent developments in 8-aminoquinoline antimalarials (Q40111614)

17 September 2017

1 reference

title

Recent developments in 8-aminoquinoline antimalarials (English)

1 reference

17 September 2017

0 references

B. K. Bhat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207558

29 August 2023

M. Seth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207558

29 August 2023

A. P. Bhaduri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207558

29 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6207558

29 August 2023

publication date

1 January 1984

1 reference

full work available at URL

17 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-0348-7118-1_6

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

29 August 2023

published in

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

197-231

1 reference

Effects of Chloroquine, Quinine, and Cycloguanil upon the Maturation of Asexual Erythrocytic Forms of Two Strains of Plasmodium Falciparum in Vitro *

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Determination of the drug sensitivity of Plasmodium falciparum

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Activity of a new antimalarial agent, pentaquine (SN 13,276)

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Mass therapy of subclinical vivax malaria with primaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Induced primaquine resistance in vivax malaria

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

The Development of a “High Volume Tissue Schizonticidal Drug Screen” Based upon Mortality of Mice Inoculated with Sporozoites of Plasmodium Berghei *

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

2,4,7-Triamino-6-ortho-substituted Arylpteridines. A New Series of Potent Antimalarial Agents

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

The activity of some antibiotics and long-acting compounds against the tissue stages ofPlasmodium berghei

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Measurement of the growth rate of the erythrocytic stages ofPlasmodium bergheiand comparisons of the potency of inocula after various treatments

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Rodent Systems (Plasmodium berghei-Anopheles stephensi) for Screening Compounds for Potential Causal Prophylaxis *

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Alkylaminoalkyl Derivatives of 8-Aminoquinoline1

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of certain 8-(5-alkylamino-1-methylpentylamino)-derivatives of quinoline

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthetic antimalarials; some derivatives of 8-aminoquinoline

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of antimalarials; synthesis of certain 8-aminoquinolines.

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

The Synthesis of Some Substituted 8-Aminoquinolines1

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of 6-phenoxy-8-(3'diethylaminopropylamino)-quinoline

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Some Derivatives of 8-Aminoquinoline1

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

5-Methyl-6-methoxy-8-(2'-diethylaminoethylamino)-quinoline1

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of 2-substituted primaquine analogs as potential antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of 2-benzyloxy and 2-benzylthio analogs of primaquine as potential antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of 4-alkyl- and 4-(.beta.-alkylvinyl) derivatives of primaquine as potential antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Synthesis of some 4-substituted 8-amino-6-methoxyquinolines as potential antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Chemotherapy of the drug-resistant malarias

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Antimalarials. 10. Synthesis of 4-substituted primaquine analogs as candidate antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

8-(Omega-aminoalkylamino)quinolines as potential prophylactic antimalarials

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Modifications of primaquine as antimalarials. 2. 5-Phenylthio and 5-anilino derivatives of primaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Modifications of primaquine as antimalarials. 1. 5-Phenoxy derivatives of primaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Modifications of primaquine as antimalarials. 3. 5-Phenoxy derivatives of primaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Antimalarials. 14. 5-(aryloxy)-4-methylprimaquine analogues. A highly effective series of blood and tissue schizonticidal agents

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Reduced 8-aminoquinoline analogues as potential antimalarial agents

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

4-[(Aminoalkyl)amino]-1,2-dimethoxynaphthalenes as antimalarial agents

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine analogs: derivatives of 4-amino-2-methoxyacridine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Antimalarials: Effects on in vivo and in vitro Protein Synthesis

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine diphosphate: inhibition of Newcastle disease virus replication

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Mode of Action of Primaquine: Preferential Inhibition of Protein Biosynthesis in Bacillus megaterium

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Phospholipid metabolism, osmotic stability and reducing potential of human red cells exposed to pentaquine and hydroxy derivatives

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Effects of antimalarial drugs and clofibrate on in vitro lipid synthesis in Tetrahymena pyriformis GL.

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Plasmodium berghei: Inhibited incorporation of AMP-8-3H into nucleic acids of erythrocyte-free malarial parasites by acridines, phenanthridines, and 8-aminoquinolines

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Inhibition of precursor incorporation into nucleic acids of mammalian tissues by antimalarial aminoquinolines

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

The inhibition in vitro of bacterial DNA polymerases and RNA polymerase by antimalarial 8-aminoquinolines and by chloroquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Quinine: effect of Tetrahymena pyriformis. 3. Energetics of isolated mitochondria in the presence of quinine and other antimalarial drugs

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Chloroquine- and primaquine-induced alterations of glucose metabolism in the uninfected red cell

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Inhibition of short-circuit current and Na+, K+-ATPase in toad bladder by primaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Studies on the chemotherapy of the human malarias; the physiological disposition of pamaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

PENTAQUINE (SN-13,276), A THERAPEUTIC AGENT EFFECTIVE IN REDUCING THE RELAPSE RATE IN VIV AX MALARIA.

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Studies on the chemotherapy of the human malarias; the antimalarial activity of pamaquine

29 August 2023

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Metabolites of pamaquine in urine

29 August 2023

104

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Microbial metabolism studies on the major microbial and mammalian metabolite of primaquine

29 August 2023

107

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Studies on Plasmodium gallinaceum in vitro II. The effects of some 8-aminoquinolines against the erythrocytic parasites

29 August 2023

108

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Dihydroorotic acid dehydrogenase: introduction into erythrocyte by the malaria parasite

29 August 2023

110

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Toxicity of primaquine in Caucasians

29 August 2023

115

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Membrane alterations in hemolysis: Internalization of plasmalemma induced by primaquine

29 August 2023

121

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance

29 August 2023

122

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Effect of pentaquine on cardiovascular system of unanesthetized dogs

29 August 2023

124

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Some antiarrhythmic actions of primaquine, amodiaquin, and quinidine

29 August 2023

127

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine inhibits mitogen-induced human lymphocyte proliferative responses

29 August 2023

128

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Comparative effects of some antimalarial drugs on isolated cardiac muscle of the guinea pig.

29 August 2023

132

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Glucose-6-phosphate dehydrogenase deficiency and related disorders of the pentose phosphate pathway

29 August 2023

133

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Plasmocid encephalopathy in the rhesus monkey: a study of selective vulnerability

29 August 2023

137

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance

29 August 2023

140

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Malaria prophylaxis and treatment in G-6-PD deficiency. An observation on the toxicity of primaquine and chloroquine

29 August 2023

141

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Primaquine induced haemolysis in G-6-PD deficient Burmese

29 August 2023

143

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Comparison of the Curative Antimalarial Activities and Toxicities of Primaquine and Its d and l Isomers

29 August 2023

147

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

Coenzyme Q. CXXII. Identification and ubiquinone-8 biosynthesized by Plasmodium knowlesi, P. cynomolgi, and P. berghei

29 August 2023

148

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

A virulent chloroquine-resistant strain of Plasmodium berghei berghei transmitted through Anopheles stephensi

29 August 2023

151

1 reference

https://api.crossref.org/works/10.1007/978-3-0348-7118-1_6

29 August 2023

Identifiers

0 references

1 reference